Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
50%(1 trials)

Phase Distribution

Ph phase_1
1
25%

Phase Distribution

1

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution1 total trials
Phase 1Safety & dosage
1(100.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

66.7%

2 of 3 finished

Non-Completion Rate

33.3%

1 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(2)
Terminated(1)
Other(1)

Detailed Status

Completed2
Withdrawn1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 1

Trials by Phase

Phase 11 (100.0%)

Trials by Status

withdrawn125%
completed250%
unknown125%

Recent Activity

0 active trials
Showing 4 of 4
completed

EmbracePlus, Care App and Aura Usability Study

NCT04807608
withdrawn

Qoos Use Sustaining Health Among patIents hOspitalized in Geriatric mediciNe (QUSHION)

NCT04103827
unknown

TIKeasy TAblet satisfaCtion (TikTac)

NCT04091152
completedphase_1

Evaluation of a Tongue Operated Assistive Technology for Individuals With Severe Paralysis

NCT01124292

Clinical Trials (4)

Showing 4 of 4 trials
NCT04807608

EmbracePlus, Care App and Aura Usability Study

Completed
NCT04103827

Qoos Use Sustaining Health Among patIents hOspitalized in Geriatric mediciNe (QUSHION)

Withdrawn
NCT04091152

TIKeasy TAblet satisfaCtion (TikTac)

Unknown
NCT01124292Phase 1

Evaluation of a Tongue Operated Assistive Technology for Individuals With Severe Paralysis

Completed

All 4 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
4